Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc (EXPO) is a global leader in multidisciplinary engineering and scientific consulting, addressing complex challenges across industries from transportation to healthcare. This page serves as the definitive source for all company announcements, financial updates, and strategic developments.
Investors and industry stakeholders will find curated EXPO news including earnings reports, partnership announcements, and operational updates. Key updates cover engineering consulting innovations, safety analysis advancements, and regulatory compliance insights that demonstrate the company's technical leadership.
Bookmark this page to track EXPO's progress in solving high-stakes technical challenges through press releases detailing new service offerings, expert commentary on industry trends, and corporate milestones. All content is verified for accuracy and updated systematically to support informed decision-making.
Exponent, Inc. (Nasdaq: EXPO) reported its Q2 2024 financial results, showing flat total revenues at $140.5 million and a 2% increase in revenues before reimbursements to $132.4 million. Net income grew 14% to $29.2 million, or $0.57 per diluted share. EBITDA increased to $39.9 million, representing 30.2% of revenues before reimbursements. The company's engineering and scientific segment, accounting for 84% of revenues, grew 4% in Q2. Despite challenges in consumer electronics and chemicals sectors, Exponent saw growth in transportation, utilities, and medical device sectors. The company raised its full-year 2024 guidance, expecting low to mid-single digit growth in revenues before reimbursements and EBITDA to be 27.5% to 28.0% of revenues before reimbursements.
Exponent (Nasdaq: EXPO) will announce its financial results for the second quarter of fiscal year 2024 on July 25, 2024, after the market closes. The results cover the period ending June 28, 2024. On the same day, CEO Dr. Catherine Corrigan and CFO Richard Schlenker will host a conference call and webcast at 4:30 p.m. ET to discuss the company's business and financial performance. Interested parties can join the live call by dialing (844) 481-2781 or (412) 317-0672, and a replay will be available until August 1, 2024, by dialing (877) 344-7529 or (412) 317-0088 with passcode 2296670#. Both the live and archived webcast will be accessible via Exponent's Investor Relations webpage.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
